A study of changes in urinary rocuronium concentration after continuous administration of rocuronium during hepatic blood flow interruption in liver resection surgery.
- Conditions
- Patients undergoing hepatectomyRocuronium, Pringle maneuver, muscle relaxant effect, hepatectomyD046650
- Registration Number
- JPRN-jRCT1031230635
- Lead Sponsor
- Yamamoto Mai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
1) Patients 20 years of age or older undergoing hepatectomy under general anesthesia
2) Cases with American Society of Anesthesiologists pre-anesthetic risk assessment 3 or less
3) Patients whose consent to participate in this study is obtained in writing.
1) Patients who do not meet the above selection criteria
2) Patients with a history of allergy to muscle relaxants
3) Patients with severe systemic complications (American Society of Anesthesiologists Preanesthetic Risk Rating 4 or higher)
4) Obese patients with a BMI of 30 or greater and patients with a body mass index of less than 18.5
5) Patients with neuromuscular diseases
6) Patients with moderate to severe hepatic dysfunction (Child-Pugh classification)
7) Patients who have refused to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method